Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Guo, Jianming Guo, Shuyan Dong, Siping

Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis

  • Western Pacific
  • China
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Widhani, A. Hasibuan, A. S. Rismawati, R. Maria, S. Koesnoe, S. Hermanadi, M. I. Ophinni, Y. Yamada, C. Harimurti, K. Sari, A. N. L. Yunihastuti, E. Djauzi, S.

Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Josiah, B. O. Uzor, C. C. Duncan, B. A. Enebeli, E. C. Otoboyor, N. L.

Efficacy, safety, and public attitude toward COVID-19 vaccines: A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Acceptance
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wu, Y. Pan, Y. Su, K. Zhang, Y. Jia, Z. Yi, J. Lv, H. Zhang, L. Xue, M. Cao, D. Jiang, J.

Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Fazlollahi, A. Zahmatyar, M. Shamekh, A. Motamedi, A. Seyedi, F. Seyedmirzaei, H. Mousavi, S. E. Nejadghaderi, S. A. Sullman, M. J. M. Kolahi, A. A. Arshi, S. Safiri, S.

Electroencephalographic findings post-COVID-19 vaccination: A systematic review of case reports and case series

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Xiang, C. Zhang, J. Zhao, F. You, Y.

Emm type distribution of group A Streptococcus in China during 1990 and 2020: a systematic review and implications for vaccine coverage

  • Western Pacific
  • China
  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Abdelhady, M. Husain, M. A. Hawas, Y. Elazb, M. A. Mansour, L. S. Mohamed, M. Abdelwahab, M. M. Aljabali, A. Negida, A.

Encephalitis following COVID-19 Vaccination: A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wang, H. Dewidar, O. Whittle, S. L. Ghogomu, E. Hazlewood, G. Leder, K. Mbuagbaw, L. Pardo Pardo, J. Robinson, P. C. Buchbinder, R. Welch, V.

Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases

  • Adults
  • Older adults
  • COVID-19
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Patikorn, C. Cho, J. Y. Lambach, P. Hutubessy, R. Chaiyakunapruk, N.

Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review

  • All age groups
  • Economic aspects
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Alahmad, G.

Ethical Challenges Involved in COVID-19 Vaccine Mandates for Children: A Systematic Review

  • Children
  • Parents/caregivers
  • COVID-19
  • Ethical issues
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...